Search results for the GEO ID: GSE1548 |
(Click on the check boxes provided under "Select for analysis", to initiate grouping) |
(Once the selection is made, click on "Add groups" in "Make groups for comparison", to make a group. Scroll down) |
|
GSM ID | GPL ID |
Select for analysis |
Title |
Source name |
Description |
Characteristics |
GSM26644 | GPL85 |
|
SHRSP control
|
SHRSP brain capillaries
|
|
6 week old SHRSP received 1% NaCl, Olmesartan (4 mg/kg body weight p.o. daily) or Lisinopril (6 mg/kg body weight/day) in order to study influence of Angiotensin II on gene expression in cerebral microcapillaries
|
Sample_geo_accession | GSM26644
| Sample_status | Public on Aug 31 2004
| Sample_submission_date | Jul 08 2004
| Sample_last_update_date | May 27 2005
| Sample_type | RNA
| Sample_channel_count | 1
| Sample_organism_ch1 | Rattus norvegicus
| Sample_taxid_ch1 | 10116
| Sample_molecule_ch1 | total RNA
| Sample_platform_id | GPL85
| Sample_contact_name | Torsten,,Kirsch
| Sample_contact_email | TKirsch@gmx.net
| Sample_contact_phone | 0049-511-5329357
| Sample_contact_institute | Medical School Hannover
| Sample_contact_address |
| Sample_contact_city | Hannover
| Sample_contact_zip/postal_code | 30161
| Sample_contact_country | Germany
| Sample_supplementary_file | ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM26nnn/GSM26644/suppl/GSM26644.CEL.gz
| Sample_supplementary_file | ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM26nnn/GSM26644/suppl/GSM26644.EXP.gz
| Sample_series_id | GSE1548
| Sample_data_row_count | 8799
| |
|
GSM26645 | GPL85 |
|
SHRSP control 2
|
SHRSP brain capillaries
|
|
6 week old SHRSP received 1% NaCl, Olmesartan (4 mg/kg body weight p.o. daily) or Lisinopril (6 mg/kg body weight/day) in order to study influence of Angiotensin II on gene expression in cerebral microcapillaries
|
Sample_geo_accession | GSM26645
| Sample_status | Public on Aug 31 2004
| Sample_submission_date | Jul 08 2004
| Sample_last_update_date | May 27 2005
| Sample_type | RNA
| Sample_channel_count | 1
| Sample_organism_ch1 | Rattus norvegicus
| Sample_taxid_ch1 | 10116
| Sample_molecule_ch1 | total RNA
| Sample_platform_id | GPL85
| Sample_contact_name | Torsten,,Kirsch
| Sample_contact_email | TKirsch@gmx.net
| Sample_contact_phone | 0049-511-5329357
| Sample_contact_institute | Medical School Hannover
| Sample_contact_address |
| Sample_contact_city | Hannover
| Sample_contact_zip/postal_code | 30161
| Sample_contact_country | Germany
| Sample_supplementary_file | ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM26nnn/GSM26645/suppl/GSM26645.CEL.gz
| Sample_supplementary_file | ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM26nnn/GSM26645/suppl/GSM26645.EXP.gz
| Sample_series_id | GSE1548
| Sample_data_row_count | 8799
| |
|
GSM26646 | GPL85 |
|
SHRSP ACEI
|
SHRSP brain capillaries
|
|
6 week old SHRSP received 1% NaCl, Olmesartan (4 mg/kg body weight p.o. daily) or Lisinopril (6 mg/kg body weight/day) in order to study influence of Angiotensin II on gene expression in cerebral microcapillaries
|
Sample_geo_accession | GSM26646
| Sample_status | Public on Aug 31 2004
| Sample_submission_date | Jul 08 2004
| Sample_last_update_date | May 27 2005
| Sample_type | RNA
| Sample_channel_count | 1
| Sample_organism_ch1 | Rattus norvegicus
| Sample_taxid_ch1 | 10116
| Sample_molecule_ch1 | total RNA
| Sample_platform_id | GPL85
| Sample_contact_name | Torsten,,Kirsch
| Sample_contact_email | TKirsch@gmx.net
| Sample_contact_phone | 0049-511-5329357
| Sample_contact_institute | Medical School Hannover
| Sample_contact_address |
| Sample_contact_city | Hannover
| Sample_contact_zip/postal_code | 30161
| Sample_contact_country | Germany
| Sample_supplementary_file | ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM26nnn/GSM26646/suppl/GSM26646.CEL.gz
| Sample_supplementary_file | ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM26nnn/GSM26646/suppl/GSM26646.EXP.gz
| Sample_series_id | GSE1548
| Sample_data_row_count | 8799
| |
|
GSM26647 | GPL85 |
|
SHRSP ACEI 2
|
SHRSP brain capillaries
|
|
6 week old SHRSP received 1% NaCl, Olmesartan (4 mg/kg body weight p.o. daily) or Lisinopril (6 mg/kg body weight/day) in order to study influence of Angiotensin II on gene expression in cerebral microcapillaries
|
Sample_geo_accession | GSM26647
| Sample_status | Public on Aug 31 2004
| Sample_submission_date | Jul 08 2004
| Sample_last_update_date | May 27 2005
| Sample_type | RNA
| Sample_channel_count | 1
| Sample_organism_ch1 | Rattus norvegicus
| Sample_taxid_ch1 | 10116
| Sample_molecule_ch1 | total RNA
| Sample_platform_id | GPL85
| Sample_contact_name | Torsten,,Kirsch
| Sample_contact_email | TKirsch@gmx.net
| Sample_contact_phone | 0049-511-5329357
| Sample_contact_institute | Medical School Hannover
| Sample_contact_address |
| Sample_contact_city | Hannover
| Sample_contact_zip/postal_code | 30161
| Sample_contact_country | Germany
| Sample_supplementary_file | ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM26nnn/GSM26647/suppl/GSM26647.CEL.gz
| Sample_supplementary_file | ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM26nnn/GSM26647/suppl/GSM26647.EXP.gz
| Sample_series_id | GSE1548
| Sample_data_row_count | 8799
| |
|
GSM26648 | GPL85 |
|
SHRSP ARB 1
|
SHRSP brain capillaries
|
|
6 week old SHRSP received 1% NaCl, Olmesartan (4 mg/kg body weight p.o. daily) or Lisinopril (6 mg/kg body weight/day) in order to study influence of Angiotensin II on gene expression in cerebral microcapillaries
|
Sample_geo_accession | GSM26648
| Sample_status | Public on Aug 31 2004
| Sample_submission_date | Jul 08 2004
| Sample_last_update_date | May 27 2005
| Sample_type | RNA
| Sample_channel_count | 1
| Sample_organism_ch1 | Rattus norvegicus
| Sample_taxid_ch1 | 10116
| Sample_molecule_ch1 | total RNA
| Sample_platform_id | GPL85
| Sample_contact_name | Torsten,,Kirsch
| Sample_contact_email | TKirsch@gmx.net
| Sample_contact_phone | 0049-511-5329357
| Sample_contact_institute | Medical School Hannover
| Sample_contact_address |
| Sample_contact_city | Hannover
| Sample_contact_zip/postal_code | 30161
| Sample_contact_country | Germany
| Sample_supplementary_file | ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM26nnn/GSM26648/suppl/GSM26648.CEL.gz
| Sample_supplementary_file | ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM26nnn/GSM26648/suppl/GSM26648.EXP.gz
| Sample_series_id | GSE1548
| Sample_data_row_count | 8799
| |
|
GSM26649 | GPL85 |
|
SHRSP ARB 2
|
SHRSP brain capillaries
|
|
6 week old SHRSP received 1% NaCl, Olmesartan (4 mg/kg body weight p.o. daily) or Lisinopril (6 mg/kg body weight/day) in order to study influence of Angiotensin II on gene expression in cerebral microcapillaries
|
Sample_geo_accession | GSM26649
| Sample_status | Public on Aug 31 2004
| Sample_submission_date | Jul 08 2004
| Sample_last_update_date | May 27 2005
| Sample_type | RNA
| Sample_channel_count | 1
| Sample_organism_ch1 | Rattus norvegicus
| Sample_taxid_ch1 | 10116
| Sample_molecule_ch1 | total RNA
| Sample_platform_id | GPL85
| Sample_contact_name | Torsten,,Kirsch
| Sample_contact_email | TKirsch@gmx.net
| Sample_contact_phone | 0049-511-5329357
| Sample_contact_institute | Medical School Hannover
| Sample_contact_address |
| Sample_contact_city | Hannover
| Sample_contact_zip/postal_code | 30161
| Sample_contact_country | Germany
| Sample_supplementary_file | ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM26nnn/GSM26649/suppl/GSM26649.CEL.gz
| Sample_supplementary_file | ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM26nnn/GSM26649/suppl/GSM26649.EXP.gz
| Sample_series_id | GSE1548
| Sample_data_row_count | 8799
| |
|
|
|
Make groups for comparisons |
(2 groups will be compared at a time) |
|
Select GSMs and click on "Add groups" |
Enter the group name here: |
|
|
|
Select expression type |
Transcripts profile based on; |
A. Differential status (Up/Down regulation) |
|
|
Regulation type |
|
Fold change |
|
p-value |
|
|
|
B. Absolute calls (Transcribed/Not-detected) |
|
|
Derive calls within/across groups |
Within groups |
|
|
Detection status |
|
Percentage detection |
|
|
Across groups |
|
|
Detection status |
First group: |
- |
Second group:
|
Percentage detection |
First group: |
- |
Second group:
|
|
|
|
Filter results by number of probes |
|
|